PH23333A - Treatment of human viral infections by dsrna combined with viral inhibitors - Google Patents
Treatment of human viral infections by dsrna combined with viral inhibitorsInfo
- Publication number
- PH23333A PH23333A PH36590A PH36590A PH23333A PH 23333 A PH23333 A PH 23333A PH 36590 A PH36590 A PH 36590A PH 36590 A PH36590 A PH 36590A PH 23333 A PH23333 A PH 23333A
- Authority
- PH
- Philippines
- Prior art keywords
- viral
- treatment
- inhibitors
- human
- dsrna
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2882387A | 1987-03-23 | 1987-03-23 | |
US07/125,097 US4950652A (en) | 1987-03-23 | 1987-11-25 | dsRNAs for combination therapy in the treatment of viral diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
PH23333A true PH23333A (en) | 1989-07-14 |
Family
ID=26704119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH36590A PH23333A (en) | 1987-03-23 | 1988-03-03 | Treatment of human viral infections by dsrna combined with viral inhibitors |
Country Status (21)
Country | Link |
---|---|
US (1) | US4950652A (no) |
EP (1) | EP0286224B1 (no) |
JP (1) | JP2656938B2 (no) |
KR (1) | KR960013435B1 (no) |
CN (1) | CN1049357C (no) |
AU (1) | AU1256288A (no) |
CA (1) | CA1316832C (no) |
DE (1) | DE3876125T2 (no) |
DK (1) | DK156688A (no) |
ES (1) | ES2066782T3 (no) |
FI (1) | FI881305A (no) |
GR (1) | GR3006340T3 (no) |
HU (1) | HUT46542A (no) |
IE (1) | IE63823B1 (no) |
IL (1) | IL85646A (no) |
NO (1) | NO881246L (no) |
NZ (1) | NZ223868A (no) |
OA (1) | OA08724A (no) |
PH (1) | PH23333A (no) |
PT (1) | PT87039B (no) |
RU (1) | RU2016572C1 (no) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6130206A (en) * | 1980-07-07 | 2000-10-10 | Hem Research, Inc. | Treating viral infections associated with chronic fatigue with dsRNA |
US9309574B1 (en) | 1984-08-22 | 2016-04-12 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Molecular cloning of HIV-1 from immortalized cell lines |
US5906980A (en) * | 1987-07-17 | 1999-05-25 | Hem Research Inc. | Treatment of hepatitis with mismatched dsRNA |
US5091374A (en) * | 1987-07-17 | 1992-02-25 | Hem Research Inc. | Double-stranded RNA correction of abnormalities in circulating immune complexes and monocyte function |
US5712257A (en) * | 1987-08-12 | 1998-01-27 | Hem Research, Inc. | Topically active compositions of mismatched dsRNAs |
US4963532A (en) * | 1987-11-25 | 1990-10-16 | Hem Research, Inc. | dsRNA-based prevention of viral escape |
US4960592A (en) * | 1989-04-17 | 1990-10-02 | Lanocare Laboratories | Lanolin and lanolin oil skin treatment composition |
US5132292A (en) * | 1990-05-25 | 1992-07-21 | Hem Research, Inc. | Treatment of viral hepatitis |
US5614504A (en) * | 1990-08-01 | 1997-03-25 | The University Of South Florida | Method of making inosine monophosphate derivatives and immunopotentiating uses thereof |
US6703418B2 (en) * | 1991-02-26 | 2004-03-09 | Unimed Pharmaceuticals, Inc. | Appetite stimulation and induction of weight gain in patients suffering from symptomatic HIV infection |
JPH06507624A (ja) * | 1991-04-16 | 1994-09-01 | ヘム・ファーマスーティカル・コーポレーション | ヌクレオシド類似体に対するウイルスの耐性の2本鎖rnaによる抑制法 |
GB9108085D0 (en) * | 1991-04-16 | 1991-06-05 | Scras | Complexes of polyadenylic acid with polyuridylic acid |
WO1993001717A1 (en) * | 1991-07-16 | 1993-02-04 | Hem Pharmaceuticals Corp. | Modulation and diagnosis of cytokine dysfunctions |
US20030207813A1 (en) * | 1996-12-09 | 2003-11-06 | G.D. Searle | Retroviral protease inhibitor combinations |
AU723537B2 (en) * | 1995-06-07 | 2000-08-31 | Trimeris Inc. | The treatment of HIV and other viral infections using combinatorial therapy |
US5834443A (en) * | 1996-05-21 | 1998-11-10 | Masiello; Domenick J. | Composition and method for treating herpes simplex |
GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
WO1998030223A1 (en) * | 1997-01-17 | 1998-07-16 | Icn Pharmaceuticals, Inc. | Cytokine related treatments of disease |
LT4475B (lt) * | 1997-02-28 | 1999-02-25 | Virmantas Stunžėnas | Informacinės ribonukleino rūgšties panaudojimas vaistinėse medžiagose, skirtose padidinti šios ribonukleino rūgšties koduojamo baltymo kiekį paciento ląstelėse |
FR2766711B1 (fr) * | 1997-08-04 | 2001-02-02 | Sod Conseils Rech Applic | Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps |
TW589189B (en) | 1997-08-04 | 2004-06-01 | Scras | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
FR2768344B1 (fr) * | 1997-08-26 | 2001-02-16 | Scras | Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale |
FR2768345B1 (fr) * | 1997-09-17 | 2001-05-04 | Scras | Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale |
FR2766715B1 (fr) * | 1997-08-04 | 2001-02-16 | Scras | Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
EP1555317B1 (en) | 1998-03-20 | 2011-09-28 | Commonwealth Scientific And Industrial Research Organisation | Synthetic genes and genetic constructs comprising the same |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
FR2776927B1 (fr) * | 1998-04-07 | 2002-07-05 | Univ Paris Curie | Compositions pour la vectorisation de molecules |
CA2361201A1 (en) | 1999-01-28 | 2000-08-03 | Medical College Of Georgia Research Institute, Inc. | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna |
US6977245B2 (en) | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
US6423885B1 (en) | 1999-08-13 | 2002-07-23 | Commonwealth Scientific And Industrial Research Organization (Csiro) | Methods for obtaining modified phenotypes in plant cells |
US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
US20080242627A1 (en) * | 2000-08-02 | 2008-10-02 | University Of Southern California | Novel rna interference methods using dna-rna duplex constructs |
DE10100588A1 (de) * | 2001-01-09 | 2002-07-18 | Ribopharma Ag | Verfahren zur Hemmung der Expression eines Zielgens |
US20020132257A1 (en) | 2001-01-31 | 2002-09-19 | Tony Giordano | Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell |
US7666674B2 (en) | 2001-07-27 | 2010-02-23 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo |
AU2002361468A1 (en) | 2001-08-14 | 2003-03-18 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human S | Method for rapid generation of mature dendritic cells |
WO2003051301A2 (en) * | 2001-12-14 | 2003-06-26 | Hemispherx Biopharma | USE OF dsRNAs IN STRATEGIC THERAPEUTIC INTERVENTION OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY |
AU2002366710A1 (en) | 2001-12-20 | 2003-07-09 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of | USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS |
US8466116B2 (en) | 2001-12-20 | 2013-06-18 | The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of CpG oligodeoxynucleotides to induce epithelial cell growth |
EP3415625A1 (en) | 2002-02-01 | 2018-12-19 | Life Technologies Corporation | Double-stranded oligonucleotides |
US20060009409A1 (en) | 2002-02-01 | 2006-01-12 | Woolf Tod M | Double-stranded oligonucleotides |
IL164354A0 (en) | 2002-04-04 | 2005-12-18 | Coley Pharm Gmbh | Immunostimulatory g,u-containing oligoribonucleotides |
US8263091B2 (en) | 2002-09-18 | 2012-09-11 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides |
US20050137154A1 (en) * | 2003-05-16 | 2005-06-23 | Hemispherx Biopharma | Treating server acute respiratory syndrome |
US20060035859A1 (en) * | 2003-05-16 | 2006-02-16 | Hemispherx Biopharma | Treating severe and acute viral infections |
US20050113292A1 (en) * | 2003-07-18 | 2005-05-26 | Vanderbilt University | Compositions of protein mimetics and methods of using same against HIV-1, SARS-coV and the like |
JP4817625B2 (ja) * | 2003-08-11 | 2011-11-16 | 一般財団法人阪大微生物病研究会 | 粘膜免疫誘導アジュバントを含む新規ワクチン |
RU2272631C2 (ru) * | 2004-04-20 | 2006-03-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" (ГНЦ ВБ "Вектор") | Синергическая композиция для ингибирования вич |
DE202005004135U1 (de) * | 2005-03-11 | 2005-05-19 | Klocke Verpackungs-Service Gmbh | Mehrkomponentenverpackung mit Applikator |
WO2007062107A2 (en) | 2005-11-25 | 2007-05-31 | Coley Pharmaceutical Gmbh | Immunostimulatory oligoribonucleotides |
CA2644670A1 (en) * | 2006-03-08 | 2008-05-08 | Hemispherx Biopharma Inc. | Broad spectrum immune and antiviral gene modulation by oral interferon |
US8075877B2 (en) | 2006-03-08 | 2011-12-13 | Hemispherx Biopharma | Broad spectrum immune and antiviral gene modulation by oral interferon |
CA2703918C (en) * | 2007-10-29 | 2016-10-18 | Cipla Limited | Solid pharmaceutical dosage forms of atazanavir and ritonavir combinations |
AU2009215128A1 (en) * | 2008-02-15 | 2009-08-20 | Hemispherx Biopharma, Inc. | Selective agonist of toll-like receptor 3 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3380200D1 (en) * | 1982-09-16 | 1989-08-24 | William Alvin Carter | Anti-proliferative action of dsnras on tumor cells |
AU572019B2 (en) * | 1985-03-16 | 1988-04-28 | Wellcome Foundation Limited, The | 3'-azido-3'-deoxythymidine |
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US4795744A (en) * | 1986-07-17 | 1989-01-03 | Hem Research, Inc. | Modulation of AIDS virus-related events by double-stranded RNAS |
CA1326450C (en) * | 1985-08-26 | 1994-01-25 | William A. Carter | Modulation of aids virus-related events by double stranded rnas (dsrnas) |
-
1987
- 1987-11-25 US US07/125,097 patent/US4950652A/en not_active Expired - Lifetime
-
1988
- 1988-03-02 AU AU12562/88A patent/AU1256288A/en not_active Abandoned
- 1988-03-02 EP EP88301824A patent/EP0286224B1/en not_active Expired - Lifetime
- 1988-03-02 DE DE8888301824T patent/DE3876125T2/de not_active Expired - Fee Related
- 1988-03-02 ES ES88301824T patent/ES2066782T3/es not_active Expired - Lifetime
- 1988-03-03 PH PH36590A patent/PH23333A/en unknown
- 1988-03-07 IL IL85646A patent/IL85646A/xx not_active IP Right Cessation
- 1988-03-11 NZ NZ223868A patent/NZ223868A/xx unknown
- 1988-03-18 FI FI881305A patent/FI881305A/fi not_active Application Discontinuation
- 1988-03-21 NO NO881246A patent/NO881246L/no unknown
- 1988-03-21 CA CA000562015A patent/CA1316832C/en not_active Expired - Fee Related
- 1988-03-22 RU SU884355439A patent/RU2016572C1/ru not_active IP Right Cessation
- 1988-03-22 IE IE83988A patent/IE63823B1/en not_active IP Right Cessation
- 1988-03-22 HU HU881441A patent/HUT46542A/hu unknown
- 1988-03-22 PT PT87039A patent/PT87039B/pt not_active IP Right Cessation
- 1988-03-22 DK DK156688A patent/DK156688A/da not_active IP Right Cessation
- 1988-03-22 KR KR1019880003033A patent/KR960013435B1/ko not_active IP Right Cessation
- 1988-03-22 JP JP63065933A patent/JP2656938B2/ja not_active Expired - Fee Related
- 1988-03-23 OA OA59306A patent/OA08724A/xx unknown
- 1988-03-23 CN CN88101606A patent/CN1049357C/zh not_active Expired - Fee Related
-
1992
- 1992-11-26 GR GR920402678T patent/GR3006340T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN88101606A (zh) | 1988-12-28 |
FI881305A (fi) | 1988-09-24 |
DK156688D0 (da) | 1988-03-22 |
HUT46542A (en) | 1988-11-28 |
KR960013435B1 (ko) | 1996-10-05 |
FI881305A0 (fi) | 1988-03-18 |
EP0286224B1 (en) | 1992-11-25 |
NZ223868A (en) | 1991-02-26 |
NO881246L (no) | 1988-09-26 |
ES2066782T3 (es) | 1995-03-16 |
KR880010777A (ko) | 1988-10-24 |
EP0286224A2 (en) | 1988-10-12 |
JPS6425A (en) | 1989-01-05 |
IE63823B1 (en) | 1995-06-14 |
DE3876125T2 (de) | 1993-06-09 |
US4950652A (en) | 1990-08-21 |
OA08724A (fr) | 1989-03-31 |
GR3006340T3 (no) | 1993-06-21 |
EP0286224A3 (en) | 1988-12-07 |
DK156688A (da) | 1988-09-24 |
IL85646A0 (en) | 1988-08-31 |
CN1049357C (zh) | 2000-02-16 |
CA1316832C (en) | 1993-04-27 |
AU1256288A (en) | 1988-09-22 |
JP2656938B2 (ja) | 1997-09-24 |
IE880839L (en) | 1988-09-23 |
IL85646A (en) | 1993-05-13 |
RU2016572C1 (ru) | 1994-07-30 |
DE3876125D1 (de) | 1993-01-07 |
PT87039A (pt) | 1988-04-01 |
PT87039B (pt) | 1992-11-30 |
NO881246D0 (no) | 1988-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH23333A (en) | Treatment of human viral infections by dsrna combined with viral inhibitors | |
EP0473576A4 (en) | Short therapeutic dsrna of defined structure | |
PH25907A (en) | Agents for the prophylaxis and therapy of retroviral infections | |
PT88684A (pt) | Metodo de tratamento fosfatidilico de doencas virais | |
ZA90245B (en) | Treatment of diseases associated with hiv infections | |
ES2025287B3 (es) | Hilos elasticos compuestos de hilos ceramicos debiles. | |
ZA835360B (en) | Use of sugar derivatives for the prophylaxis and treatment of virus infections | |
DK373688D0 (da) | Behandlingsmetode | |
GB2190682B (en) | Treatment of bio-gas | |
ZA881639B (en) | Treatment of human viral infection by dsrna combined with viral inhibitors | |
GR3000306T3 (en) | Composition for the treatment of infections | |
IE880770L (en) | Treatment of viral infections | |
IE892991L (en) | Treatment of viral infections | |
PH19915A (en) | Treatment of herpetic infection | |
IE871465L (en) | Treatment of bacterial infections | |
GB2204249B (en) | Treatment of condenser tubes | |
KR890006381U (ko) | 저주파 치료기용 맛사지 로울러 | |
ZA872553B (en) | Treatment of fungal infections | |
JPS5742586A (en) | Treatment of lightweight matter | |
IT8048117A0 (it) | Composizione per il trattamento di infezioni virali e procedimento di preparazione | |
SE8704247D0 (sv) | Method of treatment | |
IE822020L (en) | Treatment of infections | |
RO87034A2 (ro) | Medicament pentru tratamentul afectiunilor reumatismale | |
GB8828646D0 (en) | Treatment of animals | |
ATE33936T1 (de) | Apparat zur aeusseren behandlung von koerperteilen mit akustischen wellen. |